查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1672449

2025年基于横向流动免疫检测（LFIA）的快速检测全球市场报告

Lateral Flow Immunoassay (LFIA) Based Rapid Test Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 175 Pages | 商品交期: 2-10个工作天内

价格
简介目录

预计未来几年基于侧流免疫检测(LFIA) 的快速测试的市场规模将稳定成长。到 2029 年，这一数字将成长至 83 亿美元，年复合成长率（CAGR）为 3.5%。预测期内的下降可归因于全球供应链中断、监管挑战、竞争加剧、替代技术的出现以及与数位健康平台的整合等因素。预测期内的关键趋势包括开发用于多次或重复基于 LFIA 的快速测试以及结果存储和通信的先进技术、注重伙伴关係关係和协作研究、开发家用检测套组、投资用于疾病筛检和检测的基于人工智慧的测试，以及开发患者可以轻鬆获得的低成本检测套组。

品管仍然是一个关键挑战，预计将阻碍横向流动免疫检测(LFIA) 快速检测市场的成长。工资和技术投资等营运成本的不断上升正在挤压许多公司的利润率。例如，2023 年 6 月，美国非营利组织 PLOS 的一份报告强调，市场上的 LFIA 产品并不总是符合高可靠性和特异性标准。四项 LFIA 测试的回顾性评估显示，诊断效能存在相当大的差异，有些测试对 IgG 检测的准确率低至 47%。

由于慢性病盛行率不断上升，基于侧流免疫检测(LFIA) 的快速检测市场预计将出现成长。这些长期健康状况需要早期发现、就地检验和定期监测，而基于 LFIA 的快速检测可以提供快速结果，帮助管理慢性疾病。世界卫生组织 (WHO) 报告称，非传染性疾病 (NCD) 每年造成大量死亡，凸显了 LFIA 在解决心血管疾病、癌症、慢性呼吸系统疾病和糖尿病等疾病方面的作用。因此，慢性病盛行率的上升刺激了市场的发展。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通膨、地缘政治、新冠疫情、经济復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 基于全球横向流动免疫检测（LFIA）的快速检测PESTEL分析（政治、社会、技术、环境、法律因素、驱动因素、限制因素）
  • 最终用途产业分析
  • 全球基于横向流动免疫检测(LFIA) 的快速测试市场：成长率分析
  • 全球基于横向流动免疫检测(LFIA) 的快速检测市场表现：规模与成长，2019-2024 年
  • 全球基于横向流动免疫检测(LFIA) 的快速检测市场预测：2024-2029 年及 2034 年规模与成长
  • 全球基于横向流动免疫检测(LFIA) 的快速测试总目标市场 (TAM)

第六章市场区隔

  • 全球基于侧流免疫检测(LFIA) 的快速检测市场（按技术、性能和预测），2019-2024 年、2024-2029 年、2034 年
  • 竞争分析
  • 夹心试验
  • 多重检测分析
  • 全球基于侧流免疫检测(LFIA) 的快速检测市场（按应用、效能及预测），2019-2024 年、2024-2029 年、2034 年
  • 感染疾病
  • 怀孕和生育
  • 毒理学
  • 心臟标记和胆固醇检测
  • 其他用途
  • 全球基于横向流动免疫检测(LFIA) 的快速检测市场（按最终用户、性能和预测），2019-2024 年、2024-2029 年、2034 年
  • 医院和诊所
  • 诊断实验室
  • 居家护理
  • 其他最终用户
  • 全球基于侧流免疫检测(LFIA) 的快速检测市场竞争细分（按检测类型、性能和预测），2019-2024 年、2024-2029 年、2034 年
  • 直接竞争试验
  • 间接竞争试验
  • 全球基于侧流免疫检测(LFIA) 的快速检测市场（按类型、夹心法细分、绩效及预测），2019-2024 年、2024-2029 年、2034 年
  • 单步骤夹心试验
  • 两步骤夹心试验
  • 全球基于横向流动免疫检测(LFIA) 的快速检测市场，按多重检测分析细分，按类型、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 多分析物检测
  • 同时侦测多种目标

第七章 区域和国家分析

  • 全球基于横向流动免疫检测(LFIA) 的快速检测市场：按地区、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 全球基于横向流动免疫检测(LFIA) 的快速检测市场：按国家/地区、绩效及预测，2019-2024 年、2024-2029 年、2034 年

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章 澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章 德国市场

第十八章 法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章 俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章竞争格局与公司概况

  • 基于横向流动免疫检测(LFIA) 的快速侦测市场：竞争格局
  • 基于横向流动免疫检测（LFIA）的快速检测市场：公司简介
    • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • F. Hoffmann-La Roche Overview, Products and Services, Strategy and Financial Analysis
    • Quidel Corporation Overview, Products and Services, Strategy and Financial Analysis
    • Becton, Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis
    • Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis

第31章 其他大型创新企业

  • Siemens AG
  • Thermo Fisher Scientific Inc.
  • Bio-Rad Laboratories, Inc.
  • PerkinElmer Inc.
  • Hologic, Inc.
  • LTEK Co., Ltd.
  • JOYSBIO Biotechnology
  • Jiangsu Medomics Medical Technologies
  • Diagnocure
  • Ubio Biotechnology Systems
  • Elabscience（R）Immunoassay Kits
  • FyoniBio/Glycotope GmbH
  • Atomo Diagnostics Limited
  • INDICAL Bioscience
  • Lionex Gmbh

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第 35 章 高市场潜力国家、细分市场与策略

  • 2029年基于横向流动免疫检测（LFIA）的快速检测市场：提供新机会的国家
  • 2029年基于横向流动免疫检测（LFIA）的快速检测市场：细分市场将带来新机会
  • 2029年基于横向流动免疫检测（LFIA）的快速检测市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手的策略

第36章 附录

简介目录
Product Code: r25741

The rapid test based on Lateral Flow Immunoassay (LFIA) is a straightforward technology-driven diagnostic device employed for detecting the presence of specific targets, such as pathogens or biomarkers, in samples obtained from the human body. These samples encompass various bodily fluids such as urine, saliva, blood, and sweat.

The primary techniques include the competitive assay, sandwich assay, and multiplex detection assay. The competitive assay specifically determines the presence of targets, such as pathogens or biomarkers, within the collected samples. Its applications span infectious diseases, pregnancy and fertility assessments, toxicology, and others, making it applicable in diverse settings such as hospitals, clinics, diagnostic laboratories, home care, and more.

The lateral flow immunoassay (LFIA) based rapid test market research report is one of a series of new reports from The Business Research Company that provides lateral flow immunoassay (LFIA) based rapid test market statistics, including lateral flow immunoassay (LFIA) based rapid test industry global market size, regional shares, competitors with a lateral flow immunoassay (LFIA) based rapid test market share, detailed lateral flow immunoassay (LFIA) based rapid test market segments, market trends and opportunities, and any further data you may need to thrive in the lateral flow immunoassay (LFIA) based rapid test industry. This lateral flow immunoassay (LFIA) based rapid test market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The lateral flow immunoassay (LFIA) based rapid test market size has declined steeply in recent years. It decline grow from $8.03 billion in 2024 to $7.23 billion in 2025 at a compound annual growth rate (CAGR) of -9.9%. The decline in the historic period can be attributed to limited sensitivity and specificity, complexity of multiplexing, cross-reactivity issues, storage and shelf-life challenges, limited quantitative capability.

The lateral flow immunoassay (LFIA) based rapid test market size is expected to see steady growth in the next few years. It will grow to $8.3 billion in 2029 at a compound annual growth rate (CAGR) of 3.5%. The decline in the forecast period can be attributed to global supply chain disruptions, regulatory challenges, increased competition, emergence of alternative technologies, integration with digital health platforms. Major trends in the forecast period include developing advanced technologies for multiple or repetitive LFIA based rapid test and storage/ communication of results, focus on partnerships and collaborations, develop at home test kits, invest in artificial intelligence-based tests for diseases screening and detection, and should develop low-cost test kits for easy access to patients at low cost.

Quality control continues to be a significant challenge anticipated to impede the growth of the lateral flow immunoassay (LFIA) rapid test market. Rising operational costs, encompassing salaries and technology investments, have strained profit margins for numerous firms. For example, in June 2023, a report from PLOS, a US-based non-profit organization, highlighted that LFIA products available in the market do not consistently adhere to high standards of reliability and specificity. A retrospective assessment of four LFIA tests indicated considerable variability in diagnostic performance, with some tests demonstrating accuracy rates as low as 47% for IgG detection.

The lateral flow immunoassay (LFIA) based rapid test market is set to experience growth fueled by the increasing prevalence of chronic diseases. These long-term health conditions demand early detection, point-of-care testing, and regular monitoring, with LFIA-based rapid tests offering prompt results and aiding in the management of chronic diseases. The World Health Organization reports a significant number of deaths attributed to non-communicable diseases (NCDs) annually, emphasizing the role of LFIA in addressing conditions such as cardiovascular diseases, cancer, chronic respiratory diseases, and diabetes. The market is thus stimulated by the rising incidence of chronic diseases.

Major companies in the lateral flow immunoassay (LFIA)-based rapid test market are concentrating on technologies like qPCR (quantitative polymerase chain reaction) to improve the sensitivity and specificity of their tests, accelerate detection speed, and broaden the range of pathogens or biomarkers that can be identified. This focus aims to lead to more reliable and accurate diagnostic solutions for various healthcare applications. qPCR technology is a molecular biology method used to amplify and quantify DNA or RNA sequences in real time, allowing for precise measurements of gene expression levels or the detection of specific pathogens in various samples. For example, in November 2023, F. Hoffmann-La Roche AG, a Switzerland-based pharmaceutical company, introduced the LightCycler PRO System. This system builds on Roche's legacy of qPCR technologies, employing gold-standard techniques to ensure high quality, precision, and reliability-capabilities that are vital for accurate patient diagnosis and effective clinical decision-making.

Leading companies in the lateral flow immunoassay (LFIA)-based rapid test market are also investing in Integrated Health Solutions to enhance diagnostic efficiency, optimize workflows, and deliver comprehensive patient care through improved data sharing and collaboration across healthcare platforms. Integrated Health Solutions encompass comprehensive healthcare systems that link various services, technologies, and data to enhance patient care and streamline operations. For instance, in June 2024, F. Hoffmann-La Roche AG launched analytical units for its Cobas Pro integrated solutions. The Cobas Pro system can process up to 1,000 samples per hour with its sample supply unit and features high-speed analytical units capable of conducting up to 900 tests per hour for the ion-selective electrode (ISE) and 1,000 tests per hour for the Cobas C 503 unit, which specializes in clinical chemistry.

In August 2023, Danaher Corporation acquired Abcam plc for $5.7 billion, aligning with Danaher's strategy to bolster its life sciences business. The acquisition of Abcam, a UK-based biotechnology company specializing in LFIA-based rapid tests, is expected to enhance value for shareholders and deliver outstanding results for both the workforce and clients.

Major companies operating in the lateral flow immunoassay (LFIA) based rapid test market include Abbott Laboratories, F. Hoffmann-La Roche, Quidel Corporation, Becton, Dickinson and Company, Danaher Corporation, Siemens AG, Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Inc., PerkinElmer Inc., Hologic, Inc., LTEK Co., Ltd., JOYSBIO Biotechnology, Jiangsu Medomics Medical Technologies, Diagnocure, Ubio Biotechnology Systems, Elabscience(R) Immunoassay Kits, FyoniBio / Glycotope GmbH, Atomo Diagnostics Limited, INDICAL Bioscience, Lionex Gmbh, BIOMED Labordiagnostik GmbH, Charles River Laboratories, EKF Diagnostics, Launch Diagnostics, Diagnostic Instruments Ltd, Qiagen N.V., Merck KGaA, XPhyto Therapeutics, 3a Diagnostics, Roche Holding AG, BATM, Biomaxima, SensDx, Vitrosens Biotechnology, Bioeasy Biotechnology, Fujirebio, Immunodiagnostic Systems Holdings PLC, Mesa Biotech Inc, CTK Biotech

North America was the largest region in the lateral flow immunoassay (LFIA) based rapid test market in 2024. Asia-Pacific was the second largest region in the global lateral flow immunoassay (LFIA) based rapid test market. The regions covered in the lateral flow immunoassay (LFIA) based rapid test market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the lateral flow immunoassay (LFIA) based rapid test market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Canada, Spain

Lateral Flow Immunoassay (LFIA) based rapid test market consists of sales of conjugate pads, nitrocellulose membrane and absorbent pad. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Lateral Flow Immunoassay (LFIA) Based Rapid Test Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on lateral flow immunoassay (lfia) based rapid test market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for lateral flow immunoassay (lfia) based rapid test ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The lateral flow immunoassay (lfia) based rapid test market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Technique: Competitive Assay, Sandwich Assay, Multiplex Detection Assay
  • 2) By Application: Infectious Disease, Pregnancy And Fertility, Toxicology, Cardiac Marker And Cholesterol Testing, Other Applications
  • 3) By End-Users: Hospitals And Clinics, Diagnostic Laboratories, Home Care, Other End Users
  • Subsegments:
  • 1) By Competitive Assay: Direct Competitive Assays; Indirect Competitive Assays
  • 2) By Sandwich Assay: Single-step Sandwich Assays; Two-step Sandwich Assays
  • 3) By Multiplex Detection Assay: Multi-analyte Assays; Simultaneous Detection Of Various Targets
  • Companies Mentioned: Abbott Laboratories; F. Hoffmann-La Roche; Quidel Corporation; Becton, Dickinson and Company; Danaher Corporation
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Characteristics

3. Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Trends And Strategies

4. Lateral Flow Immunoassay (LFIA) Based Rapid Test Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market

5. Global Lateral Flow Immunoassay (LFIA) Based Rapid Test Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Lateral Flow Immunoassay (LFIA) Based Rapid Test PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Growth Rate Analysis
  • 5.4. Global Lateral Flow Immunoassay (LFIA) Based Rapid Test Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Lateral Flow Immunoassay (LFIA) Based Rapid Test Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Lateral Flow Immunoassay (LFIA) Based Rapid Test Total Addressable Market (TAM)

6. Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Segmentation

  • 6.1. Global Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Competitive Assay
  • Sandwich Assay
  • Multiplex Detection Assay
  • 6.2. Global Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Infectious Disease
  • Pregnancy & Fertility
  • Toxicology
  • Cardiac Marker And Cholesterol Testing
  • Other Applications
  • 6.3. Global Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospital & Clinic
  • Diagnostic Laboratory
  • Home Care
  • Other End Users
  • 6.4. Global Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Sub-Segmentation Of Competitive Assay, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Direct Competitive Assays
  • Indirect Competitive Assays
  • 6.5. Global Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Sub-Segmentation Of Sandwich Assay, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Single-step Sandwich Assays
  • Two-step Sandwich Assays
  • 6.6. Global Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Sub-Segmentation Of Multiplex Detection Assay, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Multi-analyte Assays
  • Simultaneous Detection Of Various Targets

7. Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Regional And Country Analysis

  • 7.1. Global Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Lateral Flow Immunoassay (LFIA) Based Rapid Test Market

  • 8.1. Asia-Pacific Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Lateral Flow Immunoassay (LFIA) Based Rapid Test Market

  • 9.1. China Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Overview
  • 9.2. China Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Lateral Flow Immunoassay (LFIA) Based Rapid Test Market

  • 10.1. India Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Lateral Flow Immunoassay (LFIA) Based Rapid Test Market

  • 11.1. Japan Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Overview
  • 11.2. Japan Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Lateral Flow Immunoassay (LFIA) Based Rapid Test Market

  • 12.1. Australia Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Lateral Flow Immunoassay (LFIA) Based Rapid Test Market

  • 13.1. Indonesia Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Lateral Flow Immunoassay (LFIA) Based Rapid Test Market

  • 14.1. South Korea Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Overview
  • 14.2. South Korea Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Lateral Flow Immunoassay (LFIA) Based Rapid Test Market

  • 15.1. Western Europe Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Overview
  • 15.2. Western Europe Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Lateral Flow Immunoassay (LFIA) Based Rapid Test Market

  • 16.1. UK Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Lateral Flow Immunoassay (LFIA) Based Rapid Test Market

  • 17.1. Germany Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Lateral Flow Immunoassay (LFIA) Based Rapid Test Market

  • 18.1. France Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Lateral Flow Immunoassay (LFIA) Based Rapid Test Market

  • 19.1. Italy Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Lateral Flow Immunoassay (LFIA) Based Rapid Test Market

  • 20.1. Spain Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Lateral Flow Immunoassay (LFIA) Based Rapid Test Market

  • 21.1. Eastern Europe Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Overview
  • 21.2. Eastern Europe Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Lateral Flow Immunoassay (LFIA) Based Rapid Test Market

  • 22.1. Russia Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Lateral Flow Immunoassay (LFIA) Based Rapid Test Market

  • 23.1. North America Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Overview
  • 23.2. North America Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Lateral Flow Immunoassay (LFIA) Based Rapid Test Market

  • 24.1. USA Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Overview
  • 24.2. USA Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Lateral Flow Immunoassay (LFIA) Based Rapid Test Market

  • 25.1. Canada Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Overview
  • 25.2. Canada Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Lateral Flow Immunoassay (LFIA) Based Rapid Test Market

  • 26.1. South America Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Overview
  • 26.2. South America Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Lateral Flow Immunoassay (LFIA) Based Rapid Test Market

  • 27.1. Brazil Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Lateral Flow Immunoassay (LFIA) Based Rapid Test Market

  • 28.1. Middle East Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Overview
  • 28.2. Middle East Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Lateral Flow Immunoassay (LFIA) Based Rapid Test Market

  • 29.1. Africa Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Overview
  • 29.2. Africa Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Competitive Landscape And Company Profiles

  • 30.1. Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Competitive Landscape
  • 30.2. Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Company Profiles
    • 30.2.1. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. F. Hoffmann-La Roche Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Quidel Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Becton, Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis

31. Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Other Major And Innovative Companies

  • 31.1. Siemens AG
  • 31.2. Thermo Fisher Scientific Inc.
  • 31.3. Bio-Rad Laboratories, Inc.
  • 31.4. PerkinElmer Inc.
  • 31.5. Hologic, Inc.
  • 31.6. LTEK Co., Ltd.
  • 31.7. JOYSBIO Biotechnology
  • 31.8. Jiangsu Medomics Medical Technologies
  • 31.9. Diagnocure
  • 31.10. Ubio Biotechnology Systems
  • 31.11. Elabscience(R) Immunoassay Kits
  • 31.12. FyoniBio / Glycotope GmbH
  • 31.13. Atomo Diagnostics Limited
  • 31.14. INDICAL Bioscience
  • 31.15. Lionex Gmbh

32. Global Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Lateral Flow Immunoassay (LFIA) Based Rapid Test Market

34. Recent Developments In The Lateral Flow Immunoassay (LFIA) Based Rapid Test Market

35. Lateral Flow Immunoassay (LFIA) Based Rapid Test Market High Potential Countries, Segments and Strategies

  • 35.1 Lateral Flow Immunoassay (LFIA) Based Rapid Test Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Lateral Flow Immunoassay (LFIA) Based Rapid Test Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Lateral Flow Immunoassay (LFIA) Based Rapid Test Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer